TrialPanorama/TrialPanorama-database huggingface dataset:
Primary endpoint: Proliferation and differentiation of hematopoietic stem/progenitor cells
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Padua score for medical patients
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Caprini score for surgical patients
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Cardiorespiratory fitness (CRF) response rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Variation of the RV-LSF (in %)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Renal uptake at F18-FDG PET CT
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Occurrence of Atherosclerotic Cardiovascular Disease (ASCVD) high risk rating
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Alzheimer's Disease Assessment Scale -Cognitive Subscale (ADAS-Cog)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Quality of Life-Alzheimer's Disease (QoL-AD)
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: The Neuro-psychiatric Inventory (NPI)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Maximum tolerated dose of N-AC
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: change in mean daily step count
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: change in daily step goal achievement
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: change in ovarian volume
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: change in White Blood Cell Count
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: change in Platelet Count
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Contamination with simulated virus
Endpoint domain: Adverse events/effects
Primary endpoint: Average Epidermal Growth Factor Receptor (EGFR) expression level
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of Participants Responded to MAD
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: % of Advancement of the Jaw Needed to Achieve Efficacy
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Rates of treatment responses in HDRS-17
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Percentage of participants reporting prespecified local reactions within 7 days after vaccination
Endpoint domain: Adverse events/effects
Primary endpoint: Percentage of participants reporting prespecified systemic events within 7 days after vaccination
Endpoint domain: Adverse events/effects
Primary endpoint: Percentage of participants reporting Adverse Events (AEs) within 1 month after vaccination
Endpoint domain: Adverse events/effects
Primary endpoint: Percentage of participants reporting Serious Adverse Events (SAEs) within 6 months after vaccination
Endpoint domain: Adverse events/effects
Primary endpoint: Percentage of participants reporting related Serious Adverse Events (SAEs) through 12 months after vaccination
Endpoint domain: Adverse events/effects
Primary endpoint: Economic comparison of surgical techniques
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: CD8+ T-cell count
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Desirable feasibility level
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Favorable response to Complement Inhibitors Therapy
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in cycloplegic autorefraction
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Incident rates of moderate to severe maternal depressive symptoms
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean maternal depressive symptoms
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Isometric trunk flexor muscle strength
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Isometric trunk extensor muscle strength
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Isometric trunk rotator muscle strength
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Device Effectiveness in Converting Induced Ventricular Fibrillation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Device-related Complications
Endpoint domain: Adverse events/effects
Primary endpoint: Follow-up rates
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Incidence of Ocular Adverse Events
Endpoint domain: Adverse events/effects
Primary endpoint: Number of participants with abnormal Clinical Laboratory tests
Endpoint domain: Adverse events/effects
Primary endpoint: Number of participants with abnormal ECGs
Endpoint domain: Adverse events/effects
Primary endpoint: Number of participants with abnormal Vital Signs
Endpoint domain: Adverse events/effects
Primary endpoint: Presence of residual glandular tissue
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Measurement of skin flap thickness
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Biering Sorenson Test
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Kraus Weber testi
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Lateral Bridge test
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Side bending test
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Non-invasive CVP measurement at admission and discharge
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Non-invasive CVP measurement in right and left arms
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Residual
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in image analysis based pigment intensity
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Oral mucocutaneous lesions
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Brain Imaging-fMRI
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Core Performance
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Movement Imagery Ability
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Acceptability of the remote brain health clinic
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Feasibility of the remote brain health clinic
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: tip to tip and tripod pinch strength
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: hemoglobin and serum iron levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Root mean square of each muscle activation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Pulse wave velocity at the ending of the systole of carotid artery
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Number of subjects with detectable glutamate metabolite
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Number of subjects with detectable n-acetylaspartate (NAA) metabolite
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Number of Participants With Undetectable SARS-CoV-2 at PCR at Day 7
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Number of Participants Not Requiring Oxygen Therapy and/or Mechanical Ventilation at Day 14
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Adherence to wearing CGM devices
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Number of suctioning per day
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Bone Fusion
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Accuracy of invasive diagnosis of subsolid nodules
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: recovery of pain
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Time required to achieve haemostasis
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Number of subjects in whom haemostasis was achieved within 3 minutes after administration
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Number of subjects who required a surgical revision within 12 hours after the procedure for recurrent bleeding
Endpoint domain: Adverse events/effects
Primary endpoint: Area under the concentration-time curve of ethinylestradiol in plasma (AUC0-tz)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Maximum measured concentration of ethinylestradiol in plasma (Cmax)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Area under the concentration-time curve of levonorgestrel in plasma (AUC0-tz)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Maximum measured concentration of levonorgestrel in plasma (Cmax)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Balance Scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Barriers to adherence
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Initial request for analgesia post-surgery
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Efficacy of etripamil NS
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: oral-cancer free survival
Endpoint domain: Mortality/survival
Primary endpoint: Change of ALT level
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Test Performance of AAT test
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Test Performance of IC test
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Serial performance of AAC and IC tests
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Rate of tumor deposit at the fusion site
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Presence of urinary tract stones
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Change in inflammatory characteristics
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Florida Affect Battery (FAB)
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Community Reintegration of Service Members
Endpoint domain: Life impact
Endpoint subdomain: Social functioning
Primary endpoint: Change in AST levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Change in ALP levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Change in Bilirubin blood levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Change in tacrolimus trough levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in overall daily dose of tacrolimus
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: MRI-based markers of tumor hypoxia
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Reach of ePRO monitoring
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Adoption of ePRO monitoring
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Patient-level Uptake
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Neck disability index to measure functional status of neck
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Medical outcome study (MOS-36) to measure functions of daily living
Endpoint domain: Life impact
Endpoint subdomain: Role functioning
Primary endpoint: Change from baseline using the Schiff Airblast Sensitivity Score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Validation of the biomarker
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Symbol Digit Modalities Test (SDMT) score
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Percentage of patients achieving PASI 90
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Probing depth in mm
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Bleeding on probing in percentage
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Plaque index in percentage
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: (M-)protein concentrations/light chains change
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Adherence to colposcopy visit
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Incidence of Radiotherapy-Induced Oral Mucositis
Endpoint domain: Adverse events/effects
Primary endpoint: Time to Onset of Oral Mucositis
Endpoint domain: Adverse events/effects
Primary endpoint: Severity of Oral Mucositis
Endpoint domain: Adverse events/effects
Primary endpoint: Calories delivered daily enterally and/or parenterally
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Protein delivered daily enterally and/or parenterally
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Rate of heart transplantation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Change in Family Members' Readiness for ACP at 2 Weeks
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Change in Family Members' Readiness for ACP at 3 Weeks
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Proportion of subjects with Adverse Events related to investigational product
Endpoint domain: Adverse events/effects
Primary endpoint: Content of serum metabolomics
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Proportion of patients mobilizing CD34+ cells
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Safety and tolerability of the ketogenic diet
Endpoint domain: Adverse events/effects
Primary endpoint: Cardiac electrical synchrony
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Cardiac mechanical synchrony
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Very good partial response
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Treatment-related adverse event rate
Endpoint domain: Adverse events/effects
Primary endpoint: Need for tracheostomy tube
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Functional independence measure (FIM) scale
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Fugl Meyer Assessment Scale
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: TIME UP AND GO TEST
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Rate of successful completion of the requisite EUS examination
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Cognitive and physical fatigue screen
Endpoint domain: Life impact
Endpoint subdomain: Fatigue
Primary endpoint: Refusal of co-administration
Endpoint domain: Adverse events/effects
Primary endpoint: Delirium prevention
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Improve occupational performance
Endpoint domain: Life impact
Endpoint subdomain: Role functioning
Primary endpoint: Achievement of body weight reduction ≥5%
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Changes in aerobic fitness
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Sum of Pain Intensity Differences in Pain Score Over 24 Hours
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: changes of magnitude of corneal astigmatism
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: changes of axis of corneal astigmatism
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: changes of manifest refractive astigmatism
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Safety and tolerability of tradipitant
Endpoint domain: Adverse events/effects
Primary endpoint: Change in the percent of participants using the CovidX web application
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Average compliance rate with daily symptom tracking
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Change in the Gambling Symptom Assessment Scale (G-SAS)
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Change in the Gambling-Related Cognitions Scale (GRCS-S)
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Awareness level of community on the SMA and DMD diseases
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Attitudes of community towards SMA/DMD newborn screening and carrier screening
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Public opinion towards the effectiveness of physiotherapy and rehabilitation on DMD/SMA
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Change in PTSD diagnosis and symptom severity (CAPS-5)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in PTSD diagnosis and symptom severity (PCL-5)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Suicidality over time (C-SSRS)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Suicidality throughout the study (SBQ-R)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mood and anxiety symptoms (BDI-II and STAI-Y)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Improvement of conductive hearing loss
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Neonatal fat mass
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Maximum Plasma Concentration (Cmax) of ABBV-903
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Area Under the Concentration-Time Curve From Time 0 to Infinity (AUCinf) of ABBV-903
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Maximum observed in plasma/whole blood concentration (Cmax)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Area under the plasma/whole blood concentration-time curve from time zero extrapolated to infinite time (AUC(INF))
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Terminal elimination half-life (T-HALF)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Diurnal triglyceridemia
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: 30-sec chair stand test
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Treadmill speed at anaerobic threshold
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Circadian Rhythm of cortisol
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Improvement on Clinician Administered PTSD Scale for DSM-5 (CAPS-5)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Symptom burden and functioning
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Safety and tolerability of ECT204
Endpoint domain: Adverse events/effects
Primary endpoint: Recommended Phase II Dose (RP2D) of ECT204
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Percent of Target Sample Size Accrued by Study Completion
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Anthropometric circumferences
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Swallowing Function
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Core Lower Urinary Tract Symptom Score
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Objective Response Rate (as Defined by RECIST v1.1)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes